• OPEN AN ACCOUNT
Indian Indices
Sensex
85,408.70 -116.14
( -0.14%)
Global Indices
Nasdaq
48,460.34 76.65
(0.16%)
Dow Jones
6,930.02 30.53
(0.44%)
Hang Seng
50,375.92 -36.95
(-0.07%)
Nikkei 225
9,896.28 30.31
(0.31%)
Forex
USD-INR
89.61 0.03
(0.04%)
EUR-INR
105.18 0.31
(0.29%)
GBP-INR
120.34 0.55
(0.45%)
JPY-INR
0.57 0.00
(0.36%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
139.7171745
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
44.7
23635.58
EPS(TTM)
Face Value()
Div & Yield %
31.56
10
0.85
 

Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter
Nov 05,2025
Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales14405.2213264.22 9
OPM %31.4329.70 -
PBDT4897.114223.79 16
PBT4167.613597.88 16
NP3117.953040.16 3